肝细胞-话题@MedSci

#肝细胞#

513篇内容 | 5127人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1863441, encodeId=217e1863441ec, content=<a href='/topic/show?id=c0b68135561' target=_blank style='color:#2F92EE;'>#肝细胞#</a>, objectTitle=Nature：人肝细胞图谱问世！, objectType=article, longId=175429, objectId=aca91e5429d4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=aca91e5429d4, replyNumber=0, likeNumber=90, createdTime=2020-02-05, rootId=0, userName=xjy02, userId=d59291, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=aca91e5429d4, moduleTitle=Nature：人肝细胞图谱问世！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=aca91e5429d4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1863429, encodeId=79e318634291d, content=<a href='/topic/show?id=c0b68135561' target=_blank style='color:#2F92EE;'>#肝细胞#</a>, objectTitle=Gut：有无转移，而非年龄，是影响肝细胞癌患者生存的重要因素, objectType=article, longId=162913, objectId=60c7162913bc, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=60c7162913bc, replyNumber=0, likeNumber=71, createdTime=2019-07-29, rootId=0, userName=xjy02, userId=d59291, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=60c7162913bc, moduleTitle=Gut：有无转移，而非年龄，是影响肝细胞癌患者生存的重要因素, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=60c7162913bc)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1863425, encodeId=9bb6186342518, content=<a href='/topic/show?id=c0b68135561' target=_blank style='color:#2F92EE;'>#肝细胞#</a>, objectTitle=BMC Gastroenterology：甲胎蛋白联合中性粒细胞与淋巴细胞比值对肝细胞癌的诊断价值, objectType=article, longId=160906, objectId=947a160906bf, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=947a160906bf, replyNumber=0, likeNumber=60, createdTime=2019-10-15, rootId=0, userName=xjy02, userId=d59291, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=947a160906bf, moduleTitle=BMC Gastroenterology：甲胎蛋白联合中性粒细胞与淋巴细胞比值对肝细胞癌的诊断价值, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=947a160906bf)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1863471, encodeId=2fc018634e116, content=<a href='/topic/show?id=c0b68135561' target=_blank style='color:#2F92EE;'>#肝细胞#</a>, objectTitle=Gastroenterology：多倍体肝细胞数目增加的小鼠在慢性肝损伤后也不易癌变, objectType=article, longId=186941, objectId=b3eb18694154, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b3eb18694154, replyNumber=0, likeNumber=78, createdTime=2020-08-05, rootId=0, userName=xjy02, userId=d59291, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b3eb18694154, moduleTitle=Gastroenterology：多倍体肝细胞数目增加的小鼠在慢性肝损伤后也不易癌变, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b3eb18694154)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1863467, encodeId=102f186346edd, content=<a href='/topic/show?id=c0b68135561' target=_blank style='color:#2F92EE;'>#肝细胞#</a>, objectTitle=国产肝癌创新药多纳非尼一线治疗晚期肝细胞癌III期临床研究获得成功, objectType=article, longId=185534, objectId=9c1618553426, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9c1618553426, replyNumber=0, likeNumber=71, createdTime=2020-07-25, rootId=0, userName=xjy02, userId=d59291, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9c1618553426, moduleTitle=国产肝癌创新药多纳非尼一线治疗晚期肝细胞癌III期临床研究获得成功, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9c1618553426)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1863443, encodeId=28c1186344350, content=<a href='/topic/show?id=c0b68135561' target=_blank style='color:#2F92EE;'>#肝细胞#</a>, objectTitle=J Hepatology：成功治疗早期肝细胞癌后的直接作用抗病毒药物可改善HCV肝硬化患者的生存率, objectType=article, longId=176003, objectId=fb721e600347, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fb721e600347, replyNumber=0, likeNumber=63, createdTime=2020-01-18, rootId=0, userName=xjy02, userId=d59291, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fb721e600347, moduleTitle=J Hepatology：成功治疗早期肝细胞癌后的直接作用抗病毒药物可改善HCV肝硬化患者的生存率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fb721e600347)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1863460, encodeId=a17b18634604e, content=<a href='/topic/show?id=c0b68135561' target=_blank style='color:#2F92EE;'>#肝细胞#</a>, objectTitle=吉利德的Vemlidy在III期研究中，可显著降低慢性乙型肝炎感染患者肝细胞癌的发生, objectType=article, longId=183120, objectId=cf0b18312019, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cf0b18312019, replyNumber=0, likeNumber=78, createdTime=2020-03-28, rootId=0, userName=xjy02, userId=d59291, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cf0b18312019, moduleTitle=吉利德的Vemlidy在III期研究中，可显著降低慢性乙型肝炎感染患者肝细胞癌的发生, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cf0b18312019)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1863444, encodeId=80881863444d3, content=<a href='/topic/show?id=c0b68135561' target=_blank style='color:#2F92EE;'>#肝细胞#</a>, objectTitle=Brit J Surg：经肝动脉栓塞治疗肝细胞腺瘤的安全性和疗效, objectType=article, longId=176072, objectId=e5291e60729e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e5291e60729e, replyNumber=0, likeNumber=66, createdTime=2019-07-25, rootId=0, userName=xjy02, userId=d59291, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e5291e60729e, moduleTitle=Brit J Surg：经肝动脉栓塞治疗肝细胞腺瘤的安全性和疗效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e5291e60729e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1863463, encodeId=022c1863463d3, content=<a href='/topic/show?id=c0b68135561' target=_blank style='color:#2F92EE;'>#肝细胞#</a>, objectTitle=PD-1单抗单药治疗双原发癌，局部晚期肺鳞癌肿瘤疗效PR，肝细胞癌肿瘤疗效评估pCR, objectType=article, longId=184137, objectId=74cc18413e05, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=74cc18413e05, replyNumber=0, likeNumber=78, createdTime=2020-01-31, rootId=0, userName=xjy02, userId=d59291, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=74cc18413e05, moduleTitle=PD-1单抗单药治疗双原发癌，局部晚期肺鳞癌肿瘤疗效PR，肝细胞癌肿瘤疗效评估pCR, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=74cc18413e05)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1863453, encodeId=febb1863453c7, content=<a href='/topic/show?id=c0b68135561' target=_blank style='color:#2F92EE;'>#肝细胞#</a>, objectTitle=J Hepatology：普伐他汀与索拉非尼联合治疗并未改善晚期肝细胞癌的生存率, objectType=article, longId=179354, objectId=69551e93547e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=69551e93547e, replyNumber=0, likeNumber=60, createdTime=2020-02-10, rootId=0, userName=xjy02, userId=d59291, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=69551e93547e, moduleTitle=J Hepatology：普伐他汀与索拉非尼联合治疗并未改善晚期肝细胞癌的生存率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=69551e93547e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1863461, encodeId=07731863461f5, content=<a href='/topic/show?id=c0b68135561' target=_blank style='color:#2F92EE;'>#肝细胞#</a>, objectTitle=BMS的Opdivo/Yervoy组合治疗肝细胞癌，获得FDA的优先审查, objectType=article, longId=183122, objectId=309218312237, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=309218312237, replyNumber=0, likeNumber=70, createdTime=2020-07-30, rootId=0, userName=xjy02, userId=d59291, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=309218312237, moduleTitle=BMS的Opdivo/Yervoy组合治疗肝细胞癌，获得FDA的优先审查, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=309218312237)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1863434, encodeId=993618634349f, content=<a href='/topic/show?id=c0b68135561' target=_blank style='color:#2F92EE;'>#肝细胞#</a>, objectTitle=2019 ASCO：百时美施贵宝首次发布纳武利尤单抗联合伊匹木单抗治疗晚期肝细胞癌的临床研究结果, objectType=article, longId=167618, objectId=e3fc16e61813, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e3fc16e61813, replyNumber=0, likeNumber=229, createdTime=2019-09-10, rootId=0, userName=xjy02, userId=d59291, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e3fc16e61813, moduleTitle=2019 ASCO：百时美施贵宝首次发布纳武利尤单抗联合伊匹木单抗治疗晚期肝细胞癌的临床研究结果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e3fc16e61813)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1863421, encodeId=96181863421a0, content=<a href='/topic/show?id=c0b68135561' target=_blank style='color:#2F92EE;'>#肝细胞#</a>, objectTitle=CLIN CANCER RES：索拉菲尼联合改良FOLFOX治疗晚期肝细胞癌, objectType=article, longId=158547, objectId=c8d615854e0d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c8d615854e0d, replyNumber=0, likeNumber=67, createdTime=2019-08-14, rootId=0, userName=xjy02, userId=d59291, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c8d615854e0d, moduleTitle=CLIN CANCER RES：索拉菲尼联合改良FOLFOX治疗晚期肝细胞癌, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c8d615854e0d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1863440, encodeId=cc191863440c5, content=<a href='/topic/show?id=c0b68135561' target=_blank style='color:#2F92EE;'>#肝细胞#</a>, objectTitle=肉瘤样肝细胞癌一例, objectType=article, longId=175294, objectId=25d91e529404, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=25d91e529404, replyNumber=0, likeNumber=92, createdTime=2020-05-12, rootId=0, userName=xjy02, userId=d59291, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=25d91e529404, moduleTitle=肉瘤样肝细胞癌一例, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=25d91e529404)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1863451, encodeId=51d918634519b, content=<a href='/topic/show?id=c0b68135561' target=_blank style='color:#2F92EE;'>#肝细胞#</a>, objectTitle=Radiology：钆塞酸增强MRI在肝细胞肝癌中的价值, objectType=article, longId=179004, objectId=08141e9004b4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=08141e9004b4, replyNumber=0, likeNumber=69, createdTime=2020-03-11, rootId=0, userName=医者仁心, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=08141e9004b4, moduleTitle=Radiology：钆塞酸增强MRI在肝细胞肝癌中的价值, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=08141e9004b4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1863423, encodeId=a75318634239f, content=<a href='/topic/show?id=c0b68135561' target=_blank style='color:#2F92EE;'>#肝细胞#</a>, objectTitle=Lancet Oncol：雷莫芦单抗Ⅲ期REACH-2研究获成功，AFP升高的晚期肝细胞癌患者生存期显著改善, objectType=article, longId=159866, objectId=1aab15986606, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1aab15986606, replyNumber=0, likeNumber=74, createdTime=2019-06-12, rootId=0, userName=xjy02, userId=d59291, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1aab15986606, moduleTitle=Lancet Oncol：雷莫芦单抗Ⅲ期REACH-2研究获成功，AFP升高的晚期肝细胞癌患者生存期显著改善, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1aab15986606)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1863457, encodeId=0553186345e09, content=<a href='/topic/show?id=c0b68135561' target=_blank style='color:#2F92EE;'>#肝细胞#</a>, objectTitle=Gastroenterology：与恩替卡韦相比，替诺福韦治疗HBV感染患者可降低肝细胞癌风险, objectType=article, longId=180557, objectId=f2f918055ed5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f2f918055ed5, replyNumber=0, likeNumber=89, createdTime=2020-09-02, rootId=0, userName=xjy02, userId=d59291, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f2f918055ed5, moduleTitle=Gastroenterology：与恩替卡韦相比，替诺福韦治疗HBV感染患者可降低肝细胞癌风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f2f918055ed5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1863456, encodeId=bc3a186345683, content=<a href='/topic/show?id=c0b68135561' target=_blank style='color:#2F92EE;'>#肝细胞#</a>, objectTitle=2019 ESMO：罗氏的PD-L1单抗Tecentriq与VEGF单抗Avastin联合针对无法切除的肝细胞癌患者的Ib期研究中显示出令人鼓舞的结果, objectType=article, longId=180179, objectId=775a1801e9d4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=775a1801e9d4, replyNumber=0, likeNumber=69, createdTime=2020-01-23, rootId=0, userName=xjy02, userId=d59291, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=775a1801e9d4, moduleTitle=2019 ESMO：罗氏的PD-L1单抗Tecentriq与VEGF单抗Avastin联合针对无法切除的肝细胞癌患者的Ib期研究中显示出令人鼓舞的结果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=775a1801e9d4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1863437, encodeId=7d3c186343e90, content=<a href='/topic/show?id=c0b68135561' target=_blank style='color:#2F92EE;'>#肝细胞#</a>, objectTitle=聚焦中期肝细胞癌综合治疗，TACE的选择和优化, objectType=article, longId=167922, objectId=597916e92253, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=597916e92253, replyNumber=0, likeNumber=77, createdTime=2019-10-10, rootId=0, userName=xjy02, userId=d59291, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=597916e92253, moduleTitle=聚焦中期肝细胞癌综合治疗，TACE的选择和优化, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=597916e92253)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1863433, encodeId=0e06186343385, content=<a href='/topic/show?id=c0b68135561' target=_blank style='color:#2F92EE;'>#肝细胞#</a>, objectTitle=Hepatology：三种血清生物标志物在纵向评估极早期肝细胞癌中的作用, objectType=article, longId=164661, objectId=119116466127, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=119116466127, replyNumber=0, likeNumber=83, createdTime=2019-07-16, rootId=0, userName=xjy02, userId=d59291, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=119116466127, moduleTitle=Hepatology：三种血清生物标志物在纵向评估极早期肝细胞癌中的作用, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=119116466127)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

肝细胞

2020-05-29

xjy02 (审核中...)

前往app查看评论内容

#肝细胞#

Nature：人肝细胞图谱问世！

2020-02-05

xjy02 (审核中...)

前往app查看评论内容

#肝细胞#

Gut：有无转移，而非年龄，是影响肝细胞癌患者生存的重要因素

2019-07-29

xjy02 (审核中...)

前往app查看评论内容

#肝细胞#

BMC Gastroenterology：甲胎蛋白联合中性粒细胞与淋巴细胞比值对肝细胞癌的诊断价值

2019-10-15

xjy02 (审核中...)

前往app查看评论内容

#肝细胞#

Gastroenterology：多倍体肝细胞数目增加的小鼠在慢性肝损伤后也不易癌变

2020-08-05

xjy02 (审核中...)

前往app查看评论内容

#肝细胞#

国产肝癌创新药多纳非尼一线治疗晚期肝细胞癌III期临床研究获得成功

2020-07-25

xjy02 (审核中...)

前往app查看评论内容

#肝细胞#

J Hepatology：成功治疗早期肝细胞癌后的直接作用抗病毒药物可改善HCV肝硬化患者的生存率

2020-01-18

xjy02 (审核中...)

前往app查看评论内容

#肝细胞#

吉利德的Vemlidy在III期研究中，可显著降低慢性乙型肝炎感染患者肝细胞癌的发生

2020-03-28

xjy02 (审核中...)

前往app查看评论内容

#肝细胞#

Brit J Surg：经肝动脉栓塞治疗肝细胞腺瘤的安全性和疗效

2019-07-25

xjy02 (审核中...)

前往app查看评论内容

#肝细胞#

PD-1单抗单药治疗双原发癌，局部晚期肺鳞癌肿瘤疗效PR，肝细胞癌肿瘤疗效评估pCR

2020-01-31

xjy02 (审核中...)

前往app查看评论内容

#肝细胞#

J Hepatology：普伐他汀与索拉非尼联合治疗并未改善晚期肝细胞癌的生存率

2020-02-10

xjy02 (审核中...)

前往app查看评论内容

#肝细胞#

BMS的Opdivo/Yervoy组合治疗肝细胞癌，获得FDA的优先审查

2020-07-30

xjy02 (审核中...)

前往app查看评论内容

#肝细胞#

2019 ASCO：百时美施贵宝首次发布纳武利尤单抗联合伊匹木单抗治疗晚期肝细胞癌的临床研究结果

2019-09-10

xjy02 (审核中...)

前往app查看评论内容

#肝细胞#

CLIN CANCER RES：索拉菲尼联合改良FOLFOX治疗晚期肝细胞癌

2019-08-14

xjy02 (审核中...)

前往app查看评论内容

#肝细胞#

肉瘤样肝细胞癌一例

2020-05-12

医者仁心 (审核中...)

前往app查看评论内容

#肝细胞#

Radiology：钆塞酸增强MRI在肝细胞肝癌中的价值

2020-03-11

xjy02 (审核中...)

前往app查看评论内容

#肝细胞#

Lancet Oncol：雷莫芦单抗Ⅲ期REACH-2研究获成功，AFP升高的晚期肝细胞癌患者生存期显著改善

2019-06-12

xjy02 (审核中...)

前往app查看评论内容

#肝细胞#

Gastroenterology：与恩替卡韦相比，替诺福韦治疗HBV感染患者可降低肝细胞癌风险

2020-09-02

xjy02 (审核中...)

前往app查看评论内容

#肝细胞#

2019 ESMO：罗氏的PD-L1单抗Tecentriq与VEGF单抗Avastin联合针对无法切除的肝细胞癌患者的Ib期研究中显示出令人鼓舞的结果

2020-01-23

xjy02 (审核中...)

前往app查看评论内容

#肝细胞#

聚焦中期肝细胞癌综合治疗，TACE的选择和优化

2019-10-10

xjy02 (审核中...)

前往app查看评论内容

#肝细胞#

Hepatology：三种血清生物标志物在纵向评估极早期肝细胞癌中的作用

2019-07-16

科室
- - 订阅+
  - 更多科室
工具
服务